179 related articles for article (PubMed ID: 3967224)
21. Purging of small cell lung cancer-contaminated bone marrow by monoclonal antibodies and magnetic beads.
Elias AD; Pap SA; Bernal SD
Prog Clin Biol Res; 1990; 333():263-75. PubMed ID: 2155434
[TBL] [Abstract][Full Text] [Related]
22. Serological study for in vitro use of monoclonal antibody for autologous bone marrow transplantation in null cell-type acute lymphocytic leukemia.
Sao H; Morishima Y; Ueda R; Yoshikawa S; Kodera Y; Ohno R; Takahashi T
Jpn J Cancer Res; 1985 Dec; 76(12):1212-21. PubMed ID: 3937833
[TBL] [Abstract][Full Text] [Related]
23. Elimination of chemoresistant myeloma clonogenic cells from human bone marrow by monoclonal antibody and complement.
Tong AW; Dalton WS; Tsuruo T; Fay JW; Stone MJ
Prog Clin Biol Res; 1990; 333():155-64. PubMed ID: 2308979
[TBL] [Abstract][Full Text] [Related]
24. Elimination of chemoresistant multiple myeloma clonogenic colony-forming cells by combined treatment with a plasma cell-reactive monoclonal antibody and a P-glycoprotein-reactive monoclonal antibody.
Tong AW; Lee J; Wang RM; Dalton WS; Tsuruo T; Fay JW; Stone MJ
Cancer Res; 1989 Sep; 49(17):4829-34. PubMed ID: 2569359
[TBL] [Abstract][Full Text] [Related]
25. An effective immunomagnetic method for bone marrow purging in T cell malignancies.
Wang MY; Kvalheim G; Kvaløy S; Beiske K; Jakobsen E; Wijdenes J; Pihl A; Fodstad O
Bone Marrow Transplant; 1992 May; 9(5):319-23. PubMed ID: 1617315
[TBL] [Abstract][Full Text] [Related]
26. In vitro treatment of human acute lymphocytic leukemia cells in bone marrow with a cocktail of monoclonal antibodies.
Nakamura H; Hirayama F; Tatsumi Y; Tani Y; Kubota Y; Kanakura Y; Oguma S; Ueda T; Shibata H; Masaoka T
Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():537-42. PubMed ID: 6596454
[TBL] [Abstract][Full Text] [Related]
27. Elimination of clonogenic tumor cells from bone marrow using methylprednisolone (MP) and etoposide VP16: an in vitro pharmacologic study.
Miller G; Brashear T; Stone M; Fay J
Int J Cell Cloning; 1991 Sep; 9(5):503-10. PubMed ID: 1955738
[TBL] [Abstract][Full Text] [Related]
28. Preclinical evaluation of immunoconjugates consisting of doxorubicin linked to complement-fixing monoclonal antibody DLC-48 for bone marrow purging of B-cell lymphomas.
Winter JN; Bass B; Bringman T; Nedwin G
Prog Clin Biol Res; 1990; 333():171-83. PubMed ID: 2408059
[TBL] [Abstract][Full Text] [Related]
29. Elimination of clonogenic breast cancer cells from human bone marrow. A comparison of immunotoxin treatment with chemoimmunoseparation using 4-hydroperoxycyclophosphamide, monoclonal antibodies, and magnetic microspheres.
O'Briant KC; Shpall EJ; Houston LL; Peters WP; Bast RC
Cancer; 1991 Sep; 68(6):1272-8. PubMed ID: 1873781
[TBL] [Abstract][Full Text] [Related]
30. In vitro bone marrow purging of multidrug-resistant cells with a mouse monoclonal antibody directed against Mr 170,000 glycoprotein and a saporin-conjugated anti-mouse antibody.
Dinota A; Tazzari PL; Michieli M; Visani G; Gobbi M; Bontadini A; Tassi C; Fanin R; Damiani D; Grandi M
Cancer Res; 1990 Jul; 50(14):4291-4. PubMed ID: 1694719
[TBL] [Abstract][Full Text] [Related]
31. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
[TBL] [Abstract][Full Text] [Related]
32. Antigenic heterogeneity among Burkitt's lymphoma cells surviving treatment with monoclonal antibody and complement.
De Fabritiis P; Bregni M; Lipton J; Reynolds C; Nadler L; Ritz J; Bast RC
Leuk Res; 1986; 10(1):35-42. PubMed ID: 2935682
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of a combined treatment with ASTA-Z 7654 and VP16-213 in vitro in eradicating clonogenic tumor cells from human bone marrow.
De Fabritiis P; Pulsoni A; Sandrelli A; Simone F; Amadori S; Meloni G; Mandelli F
Bone Marrow Transplant; 1987 Oct; 2(3):287-98. PubMed ID: 3502785
[TBL] [Abstract][Full Text] [Related]
34. Elimination of drug-resistant myeloma tumor cell lines by monoclonal anti-P-glycoprotein antibody and rabbit complement.
Kulkarni SS; Wang ZM; Spitzer G; Taha M; Hamada H; Tsuruo T; Dicke KA
Blood; 1989 Nov; 74(6):2244-51. PubMed ID: 2572283
[TBL] [Abstract][Full Text] [Related]
35. Elimination of small cell lung cancer cells in vitro from human bone marrow by a monoclonal antibody.
Okabe T; Kaizu T; Ozawa K; Urabe A; Takaku F
Cancer Res; 1985 May; 45(5):1930-3. PubMed ID: 2985239
[TBL] [Abstract][Full Text] [Related]
36. Cryopreservation of human bone marrow after purging T-cells or tumor cells.
Zhang ZX; Xu YJ; Chen Y; Li Y; Shen BF; Bai Y
Cryobiology; 1994 Oct; 31(5):478-82. PubMed ID: 7988157
[TBL] [Abstract][Full Text] [Related]
37. Limiting dilution analysis for detection of residual leukemic cells after bone marrow combined decontamination with mafosfamide followed by merocyanine-540-mediated photosensitization.
Porcellini A; Rossi MT; Manna A; Sparaventi G; Pazzaglia C
Int J Cell Cloning; 1989 Jul; 7(4):223-31. PubMed ID: 2671163
[TBL] [Abstract][Full Text] [Related]
38. Distinct reactivity of Burkitt's lymphoma cell lines with eight monoclonal antibodies correlated with the ethnic origin.
Favrot MC; Philip I; Philip T; Portoukalian J; Doré JF; Lenoir GM
J Natl Cancer Inst; 1984 Oct; 73(4):841-7. PubMed ID: 6592381
[TBL] [Abstract][Full Text] [Related]
39. Immunomagnetic bone marrow purging of common acute lymphoblastic leukemia cells: suitability of BioMag particles.
Trickett AE; Ford DJ; Lam-Po-Tang PR; Vowels MR
Bone Marrow Transplant; 1991 Mar; 7(3):199-203. PubMed ID: 2059757
[TBL] [Abstract][Full Text] [Related]
40. T-cell depletion of Cercopithecus aethiops monkey bone marrow with Campath-1 monoclonal antibody and complement.
Phan DT; Barta E; Gidáli J; Fehér I; Harsányi V; Petrányi GG; Hollán SR
Haematologia (Budap); 1987; 20(3):155-63. PubMed ID: 3500899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
